alexa Treatment Of Musculoskeletal Injuries With Homologous Platelet Rich Plasma Injection
ISSN: 2167-1079

Primary Healthcare: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

3rd Annual Congress & Medicare Expo on Primary Healthcare, Clinical & Medical Case Reports
April 17-19, 2017 Dubai, UAE

Zeynep Altuntas, Mahmut Altuntas and Nedim Savac
Necmettin Erbakan University, Turkey
ScientificTracks Abstracts: Primary Health Care
DOI: 10.4172/2167-1079-C1-005
Statement of the Problem: Recently, autologous platelet rich plasma are being used to treat acute and chronic injuries in an attempt to jump start healing due to being too much growth factor source. However, the homologous (allogenic) platelet rich plasma has been investigated in several studies to treat chronic wounds. To the best of our knowledge, it has not been studied as injection for articular and soft tissue injuries. In this study, our objective was to treat different kinds of soft tissue and joint disorders with homologous platelet rich plasma and investigate the effects of it. Methods: We applied 164 injections of homologous PRP to 109 patients. 63 patients had knee pain, 12 patients had temporomandibular joint pain, 7 patients had tennis elbow, 9 patients had shoulder pain, 15 patients had lumbar pain, 3 patients had pain on the Achilles tendon. The 139 injections were made intra-articulary and 25 injections were applied into the the soft tissue. We repeated the injection in 16 patients. All of the patients were followed for one year. Findings: No severe adverse events or complications related to the injections were observed during the treatment or follow-up period. All of the patients were very satisfied with the treatment and had reported pain relief and increase of their life standarts. Second session were performed to the 17 patients after six months due to the resumption of their aches. However , they were also reported significant increase in the quality of their lives. Conclusion & Significance: This study showed homologous PRP could be safely used without complications or adverse effects. Additionally, all of the patients reported a significant satisfication from the treatment.

Zeynep Altuntas has completed his PhD from Necmettin Erbakan University, Meram School of Medicine. In 2005, she worked at the Mayo Clinic as a Research Fellow. In 2007, she received Plastic and Reconstructive Surgery expertise from Necmettin Erbakan Universty. She has published more than 20 papers in reputed journals. She studies on wound healing and regenerative medicine.

Email: [email protected]

image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version